SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States District Court for the District of Delaware. The jury found that Invitae’s products using Anchored…
Source: www.marketscreener.com – Read more
Invitae to Appeal Trial Verdict
Must Read
Whose Data Breach Is It Anyway? | Gardner Law
As the privacy and cybersecurity landscape evolves, drug and device makers face increased challenges in mergers and acquisitions. Privacy and cybersecurity risks directly impact...
